A citation-based method for searching scientific literature

Yoshitaka Kumakura, Paul Cumming. Neuroscientist 2009
Times Cited: 88







List of co-cited articles
1186 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The test-retest reliability of 18F-DOPA PET in assessing striatal and extrastriatal presynaptic dopaminergic function.
Alice Egerton, Arsime Demjaha, Philip McGuire, Mitul A Mehta, Oliver D Howes. Neuroimage 2010
71
36

Elevated striatal dopamine function linked to prodromal signs of schizophrenia.
Oliver D Howes, Andrew J Montgomery, Marie-Claude Asselin, Robin M Murray, Isabel Valli, Paul Tabraham, Elvira Bramon-Bosch, Lucia Valmaggia, Louise Johns, Matthew Broome,[...]. Arch Gen Psychiatry 2009
476
29

Dopamine synthesis capacity before onset of psychosis: a prospective [18F]-DOPA PET imaging study.
Oliver D Howes, Subrata K Bose, Federico Turkheimer, Isabel Valli, Alice Egerton, Lucia R Valmaggia, Robin M Murray, Philip McGuire. Am J Psychiatry 2011
219
23

The nature of dopamine dysfunction in schizophrenia and what this means for treatment.
Oliver D Howes, Joseph Kambeitz, Euitae Kim, Daniel Stahl, Mark Slifstein, Anissa Abi-Dargham, Shitij Kapur. Arch Gen Psychiatry 2012
522
23


Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia.
Andreas Meyer-Lindenberg, Robert S Miletich, Philip D Kohn, Giuseppe Esposito, Richard E Carson, Mario Quarantelli, Daniel R Weinberger, Karen Faith Berman. Nat Neurosci 2002
449
20


Elevated [18F]fluorodopamine turnover in brain of patients with schizophrenia: an [18F]fluorodopa/positron emission tomography study.
Yoshitaka Kumakura, Paul Cumming, Ingo Vernaleken, Hans-Georg Buchholz, Thomas Siessmeier, Andreas Heinz, Thorsten Kienast, Peter Bartenstein, Gerhard Gründer. J Neurosci 2007
97
19

Progressive increase in striatal dopamine synthesis capacity as patients develop psychosis: a PET study.
O Howes, S Bose, F Turkheimer, I Valli, A Egerton, D Stahl, L Valmaggia, P Allen, R Murray, P McGuire. Mol Psychiatry 2011
160
19

Elevated dopa decarboxylase activity in living brain of patients with psychosis.
J Reith, C Benkelfat, A Sherwin, Y Yasuhara, H Kuwabara, F Andermann, S Bachneff, P Cumming, M Diksic, S E Dyve,[...]. Proc Natl Acad Sci U S A 1994
239
19

Increased synaptic dopamine function in associative regions of the striatum in schizophrenia.
Lawrence S Kegeles, Anissa Abi-Dargham, W Gordon Frankle, Roberto Gil, Thomas B Cooper, Mark Slifstein, Dah-Ren Hwang, Yiyun Huang, Suzanne N Haber, Marc Laruelle. Arch Gen Psychiatry 2010
340
18

Increased baseline occupancy of D2 receptors by dopamine in schizophrenia.
A Abi-Dargham, J Rodenhiser, D Printz, Y Zea-Ponce, R Gil, L S Kegeles, R Weiss, T B Cooper, J J Mann, R L Van Heertum,[...]. Proc Natl Acad Sci U S A 2000
664
18

Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort.
A Abi-Dargham, R Gil, J Krystal, R M Baldwin, J P Seibyl, M Bowers, C H van Dyck, D S Charney, R B Innis, M Laruelle. Am J Psychiatry 1998
560
18

Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia.
J Hietala, E Syvälahti, H Vilkman, K Vuorio, V Räkköläinen, J Bergman, M Haaparanta, O Solin, M Kuoppamäki, E Eronen,[...]. Schizophr Res 1999
176
17

Presynaptic striatal dopamine dysfunction in people at ultra-high risk for psychosis: findings in a second cohort.
Alice Egerton, Christopher A Chaddock, Toby T Winton-Brown, Michael A P Bloomfield, Sagnik Bhattacharyya, Paul Allen, Philip K McGuire, Oliver D Howes. Biol Psychiatry 2013
137
17

Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: amphetamine-induced dopamine release in the functional subdivisions of the striatum.
Diana Martinez, Mark Slifstein, Allegra Broft, Osama Mawlawi, Dah-Ren Hwang, Yiyun Huang, Thomas Cooper, Lawrence Kegeles, Eric Zarahn, Anissa Abi-Dargham,[...]. J Cereb Blood Flow Metab 2003
427
15

Presynaptic dopaminergic dysfunction in schizophrenia: a positron emission tomographic [18F]fluorodopa study.
Stephen McGowan, Andrew D Lawrence, Tim Sales, Digby Quested, Paul Grasby. Arch Gen Psychiatry 2004
149
15

Dopamine synthesis capacity in patients with treatment-resistant schizophrenia.
Arsime Demjaha, Robin M Murray, Philip K McGuire, Shitij Kapur, Oliver D Howes. Am J Psychiatry 2012
192
15

A reversible tracer analysis approach to the study of effective dopamine turnover.
V Sossi, D J Doudet, J E Holden. J Cereb Blood Flow Metab 2001
52
25

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects.
M Laruelle, A Abi-Dargham, C H van Dyck, R Gil, C D D'Souza, J Erdos, E McCance, W Rosenblatt, C Fingado, S S Zoghbi,[...]. Proc Natl Acad Sci U S A 1996
920
14

Pharmacokinetics of plasma 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine ([18F]Fdopa) in humans.
P Cumming, G C Léger, H Kuwabara, A Gjedde. J Cereb Blood Flow Metab 1993
69
17

Increased dopamine transmission in schizophrenia: relationship to illness phases.
M Laruelle, A Abi-Dargham, R Gil, L Kegeles, R Innis. Biol Psychiatry 1999
490
13

Striatal dopamine synthesis capacity in twins discordant for schizophrenia.
P Shotbolt, P R Stokes, S F Owens, T Toulopoulou, M M Picchioni, S K Bose, R M Murray, O D Howes. Psychol Med 2011
37
32

Increased stress-induced dopamine release in psychosis.
Romina Mizrahi, Jean Addington, Pablo M Rusjan, Ivonne Suridjan, Alvina Ng, Isabelle Boileau, Jens C Pruessner, Gary Remington, Sylvain Houle, Alan A Wilson. Biol Psychiatry 2012
170
13

Subchronic haloperidol downregulates dopamine synthesis capacity in the brain of schizophrenic patients in vivo.
Gerhard Gründer, Ingo Vernaleken, Matthias J Müller, Eugen Davids, Nilufar Heydari, Hans-Georg Buchholz, Peter Bartenstein, Ole L Munk, Peter Stoeter, Dean F Wong,[...]. Neuropsychopharmacology 2003
70
17

Baseline and amphetamine-stimulated dopamine activity are related in drug-naïve schizophrenic subjects.
Anissa Abi-Dargham, Elsmarieke van de Giessen, Mark Slifstein, Lawrence S Kegeles, Marc Laruelle. Biol Psychiatry 2009
128
12

A Test of the Transdiagnostic Dopamine Hypothesis of Psychosis Using Positron Emission Tomographic Imaging in Bipolar Affective Disorder and Schizophrenia.
Sameer Jauhar, Matthew M Nour, Mattia Veronese, Maria Rogdaki, Ilaria Bonoldi, Matilda Azis, Federico Turkheimer, Philip McGuire, Allan H Young, Oliver D Howes. JAMA Psychiatry 2017
81
13

Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data.
C S Patlak, R G Blasberg, J D Fenstermacher. J Cereb Blood Flow Metab 1983
11

Dopamine in schizophrenia: a review and reconceptualization.
K L Davis, R S Kahn, G Ko, M Davidson. Am J Psychiatry 1991
11

Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method.
A Breier, T P Su, R Saunders, R E Carson, B S Kolachana, A de Bartolomeis, D R Weinberger, N Weisenfeld, A K Malhotra, W C Eckelman,[...]. Proc Natl Acad Sci U S A 1997
869
11

Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients.
J Hietala, E Syvälahti, K Vuorio, V Räkköläinen, J Bergman, M Haaparanta, O Solin, M Kuoppamäki, O Kirvelä, U Ruotsalainen. Lancet 1995
244
11

Increased dopamine synthesis rate in medial prefrontal cortex and striatum in schizophrenia indicated by L-(beta-11C) DOPA and PET.
L H Lindström, O Gefvert, G Hagberg, T Lundberg, M Bergström, P Hartvig, B Långström. Biol Psychiatry 1999
196
11

Midbrain dopamine function in schizophrenia and depression: a post-mortem and positron emission tomographic imaging study.
Oliver D Howes, Matthew Williams, Kemal Ibrahim, Garret Leung, Alice Egerton, Philip K McGuire, Federico Turkheimer. Brain 2013
85
11

Determinants of treatment response in first-episode psychosis: an 18F-DOPA PET study.
Sameer Jauhar, Mattia Veronese, Matthew M Nour, Maria Rogdaki, Pamela Hathway, Federico E Turkheimer, James Stone, Alice Egerton, Philip McGuire, Shitij Kapur,[...]. Mol Psychiatry 2019
38
26

Age-dependent decline of steady state dopamine storage capacity of human brain: an FDOPA PET study.
Yoshitaka Kumakura, Ingo Vernaleken, Hans-Georg Buchholz, Per Borghammer, Erik Danielsen, Gerhard Gründer, Andreas Heinz, Peter Bartenstein, Paul Cumming. Neurobiol Aging 2010
35
25

Modulation of [18F]fluorodopa (FDOPA) kinetics in the brain of healthy volunteers after acute haloperidol challenge.
Ingo Vernaleken, Yoshitaka Kumakura, Paul Cumming, Hans-Georg Buchholz, Thomas Siessmeier, Peter Stoeter, Matthias J Müller, Peter Bartenstein, Gerhard Gründer. Neuroimage 2006
54
16

Abnormal frontostriatal interactions in people with prodromal signs of psychosis: a multimodal imaging study.
Paolo Fusar-Poli, Oliver D Howes, Paul Allen, Matthew Broome, Isabel Valli, Marie-Claude Asselin, Paul M Grasby, Philip K McGuire. Arch Gen Psychiatry 2010
185
10

Molecular imaging studies of the striatal dopaminergic system in psychosis and predictions for the prodromal phase of psychosis.
Oliver D Howes, Andrew J Montgomery, Marie-Claude Asselin, Robin M Murray, Paul M Grasby, Philip K McGuire. Br J Psychiatry Suppl 2007
99
10


Classification of schizophrenic patients and healthy controls using [18F] fluorodopa PET imaging.
Subrata K Bose, Federico E Turkheimer, Oliver D Howes, Mitul A Mehta, Rhian Cunliffe, Paul R Stokes, Paul M Grasby. Schizophr Res 2008
43
20

Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States.
Alison R Yung, Hok Pan Yuen, Patrick D McGorry, Lisa J Phillips, Daniel Kelly, Margaret Dell'Olio, Shona M Francey, Elizabeth M Cosgrave, Eoin Killackey, Carrie Stanford,[...]. Aust N Z J Psychiatry 2005
10

6-(18)F-DOPA PET study in patients with schizophrenia. Positron emission tomography.
A M Elkashef, D Doudet, T Bryant, R M Cohen, S H Li, R J Wyatt. Psychiatry Res 2000
74
12

A neural substrate of prediction and reward.
W Schultz, P Dayan, P R Montague. Science 1997
10

Dopamine function in cigarette smokers: an [¹⁸F]-DOPA PET study.
Michael A P Bloomfield, Fiona Pepper, Alice Egerton, Arsime Demjaha, Gianpaolo Tomasi, Elias Mouchlianitis, Levi Maximen, Mattia Veronese, Federico Turkheimer, Sudhakar Selvaraj,[...]. Neuropsychopharmacology 2014
33
27

Regulation of dopaminergic function: an [18F]-DOPA PET apomorphine challenge study in humans.
S Jauhar, M Veronese, M Rogdaki, M Bloomfield, S Natesan, F Turkheimer, S Kapur, O D Howes. Transl Psychiatry 2017
20
45

Presynaptic Dopamine Capacity in Patients with Treatment-Resistant Schizophrenia Taking Clozapine: An [18F]DOPA PET Study.
Euitae Kim, Oliver D Howes, Mattia Veronese, Katherine Beck, Seongho Seo, Jin Woo Park, Jae Sung Lee, Yun-Sang Lee, Jun Soo Kwon. Neuropsychopharmacology 2017
48
18

Defining the Locus of Dopaminergic Dysfunction in Schizophrenia: A Meta-analysis and Test of the Mesolimbic Hypothesis.
Robert McCutcheon, Katherine Beck, Sameer Jauhar, Oliver D Howes. Schizophr Bull 2018
59
15

Dopamine storage capacity in caudate and putamen of patients with early Parkinson's disease: correlation with asymmetry of motor symptoms.
Yoshitaka Kumakura, Albert Gjedde, Erik H Danielsen, Søren Christensen, Paul Cumming. J Cereb Blood Flow Metab 2006
33
24

Increased frontal [(18)F]fluorodopa uptake in early Parkinson's disease: sex differences in the prefrontal cortex.
V Kaasinen, E Nurmi, A Brück, O Eskola, J Bergman, O Solin, J O Rinne. Brain 2001
111
9

Simple ratio analysis of 18F-fluorodopa uptake in striatal subregions separates patients with early Parkinson disease from healthy controls.
Pekka Jokinen, Hans Helenius, Elina Rauhala, Anna Brück, Olli Eskola, Juha O Rinne. J Nucl Med 2009
45
17


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.